Defining the progression of normal and non-progression humeral shaft fracture healing using the plasma proteome
Abstract
ABSTRACT Current diagnostic tools are neither informative of, nor concurrent with the underlying biological processes of fracture healing. We examined if there would be protein markers in the plasma of non-operatively fixed, isolated, non-articular, humeral fractures that would be informative of these biological processes. Five follow-up visits over a six-month period were examined in 24 patients that healed (union) and 7 non-healers (nonunion). Using the first or last clinic visit as the reference, 118 proteins out of ∼7000 proteins that were assayed, showed differential expression at log 2 fold change ≥1.3 fold and a significance of FDR ≤ 0.5. Multiple proteins related to endochondral bone development showed significant increased plasma levels during the first 12-16 weeks. Proteins associated with acute phase response, inflammation and lipid storage showed decreased levels after their initial induction. Using a time point to time point comparison for the first three follow-up visits (up to 9 weeks after injury) between healed and nonunion patients, identified 41 proteins with differential levels at p ≤ 0.05 significance, with ten overlapping the 118 proteins that tracked normal healing. The differential group associated with the nonunion patient‘s included specific extracellular matrix and acute phase proteins that showed decreased levels relative to normal healers. These data establish the progression of endochondral bone formation and place them in context to radiological and functional outcomes in human fracture healing. The identification of differentially expressed proteins in nonunion plasma suggests the potential for the development of diagnostic markers for the early intervention of nonunion. ClinicalTrials.gov# NCT05143476 Sponsor/Funding Source DOD W81XWH-19-1-0796
// Source
Authors: Serkalem Demisse, Avani Vaishnav, Suna Chung, Trisha Chaffee, Robert Azario, Jason Lowe, Robert O’Toole, David B. Weiss, George Hanson, Renan Castillo, METRC Writing Group Members, Louis C. Gerstenfeld, Serkalem Demissie (28826), Nazanin Nafisi, Suna Chung, Paul Tornetta, Avani Sudhir Vaishnav, David S. Weiss, Glenn D. Hanson, Joseph Thomas Patterson, Robert V. O’Toole, Paul Edward Matuszewski, Roman M. Natoli, Rudy Castillo, METRC Corporate Authorship Members, Olutayo M. Alese, Todd McKinley, Yohan Jang, Luke A. Lopas, Walter W. Virkus, W. Andrew Eglseder, Andrea L. Howe, Kameron M. Kraus, David Wilson Skinner, Joshua L. Gary, Michael M. Hadeed, Tina Daoud, Eric D. McVey
Institutions: University of Maryland, Baltimore, Johns Hopkins University, Harvard University, University of Virginia, Boston University, University of Southern California, University of Arizona, University of Maryland Medical Center, University of Kentucky, Beth Israel Deaconess Medical Center, Boston Medical Center, Indiana University Indianapolis, Methodist Hospital, University of Virginia Health System